Insilico is also advancing its proprietary AI system, “pharma.ai,” integrating biology, chemistry, and clinical medicine.Insilico is also advancing its proprietary AI system, “pharma.ai,” integrating biology, chemistry, and clinical medicine. Read More
Artificial Intelligence, Investments, News, Startup Arena, ai, China, Insilico Medicine, IPO Tech in Asia
